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In this issue of the Journal, Lo et al. (1998) describe
their experiences with the novel application of a real-
time quantitative PCR assay designed to measure the
concentration of fetal DNA in maternal plasma and se-
rum samples. Their system, which uses a 5′ nuclease and
fluorescent primers, permits continuous optical moni-
toring of the progress of an amplification reaction, and
it is sensitive enough to detect the DNA in the equivalent
of 1 male fetal cell against a background of 12,800 fe-
male-genome equivalents. The data presented in that ar-
ticle demonstrate the reproducibility of this system.
Lo et al. (1998) used SRY, a single-copy Y chromo-
some–specific sequence, to quantify the number of ge-
nome equivalents per milliliter of blood when the preg-
nant woman carries a male fetus. SRY was chosen
because of the obvious lack of this sequence in the
mother. SRY sequences were never detected in nonpreg-
nant women but were detected in all pregnant women
carrying male fetuses, as early as 7 wk of gestation. These
findings are in agreement with the previous reports of
the other groups, who used less-sensitive PCR methods
(Thomas et al. 1995). Furthermore, Lo et al. did not
detect any evidence of SRY when a prior child had been
male but the current fetus was female.
The results of this study demonstrate surprisingly high
mean concentrations of fetal DNA (3.4%–6.2%) in total
maternal plasma DNA, with the mean fetal DNA con-
centrations increasing 12-fold over the course of preg-
nancy. The fractional concentration of fetal DNA in se-
rum was significantly less because of the increased
amount of total DNA in serum, presumably because of
cellular lysis occurring during coagulation. These results
validate and extend the prior work of Lo et al. (1997),
which showed that fetal DNA could be reliably detected
in as little as 10 ml of maternal plasma.
How do the results compare with those reported in
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previous studies? Almost all prior investigations have
focused on complete and intact fetal cells in the maternal
circulation, so that their nuclei are available for either
cell culture or interphase cytogenetic analysis using chro-
mosome-specific probes. Many laboratory groups have
attempted to quantify the amount of fetal cells in ma-
ternal blood (Ganshirt-Ahlert et al. 1990; Reading et al.
1995; Lewis et al. 1996; Sohda et al. 1997). These re-
ports cannot be compared with each other because dif-
ferent methods of cell preparation were used. For ex-
ample, Hamada et al. (1993) treated 2 ml of maternal
peripheral blood with a hypotonic solution, followed by
fixative and FISH. They performed manual observation
of nuclei bearing a hybridization signal with a Y chro-
mosome–specific probe (Hamada et al. 1993). They ob-
served only 2 fetal cells in 770,000 cells examined in
eight subjects carrying male fetuses at !15 wk of ges-
tation. A significantly higher frequency was reported by
Watchel et al. (1996), who used charge-flow–separation
techniques and estimated that thousands of fetal cells
were present in maternal blood samples.
Most PCR-based noninvasive prenatal diagnostic
studies have also used DNA prepared from intact fetal
and maternal cells. In the past, the plasma has been
discarded. This was the approach taken in a previous
study reported by Bianchi et al. (1997), in which a ra-
dioactive quantitative PCR was employed in an assay to
measure the number of fetal cell DNA equivalents in 16
ml of maternal blood samples (Bianchi et al. 1997). The
mean number of male DNA equivalents in samples ob-
tained fromwomen carrying karyotypically normalmale
pregnancies was 19, or ∼1.2/ml of whole blood. Lo et
al. (1998) expressed their results as copies of SRY per
milliliter and demonstrated a mean of 25.4 copies in the
maternal plasma samples obtained early in pregnancy.
Many mechanisms could explain the notable findings
of Lo et al. (1998). One possibility is that there is con-
tinuous leakage or transfer of fetal cells across the pla-
centa but that the maternal immune system rapidly de-
stroys the material, leaving DNA remaining in the
plasma. This would imply that investigators who isolate
fetal cells from maternal blood are seeing only a limited
fraction of what was once there. An alternative expla-
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nation is that there is active remodeling of the placenta
at the fetal/maternal interface, with continuous cell lysis
and release of fetal DNA into the maternal circulation.
A third explanation, as Lo et al. (1998) suggest, is that
developmentally associated apoptosis of fetal cells may
be occurring. A combination of several factors may ex-
plain the results. In any event, it is intriguing that the
fetal DNA remaining from the disintegrating cells is not
further metabolized and can be detected by this assay.
In reviewing the data presented in Lo et al.’s (1998)
current study, one cannot help but notice the rather
sharp increase in the amount of fetal DNA detected dur-
ing the last 8 wk of pregnancy. The data shown dem-
onstrate an overall increase in fetal DNA concentration
as gestation advances, but it is the sharp increase de-
picted in Lo et al.’s figure 2 that is remarkable. Does
this correlate with the peak phase of fetal growth (in the
third trimester) or does this imply that, at the micro-
scopic level, the placental barrier is breaking down in
anticipation of the upcoming delivery?
The normative values established by Lo et al. (1998)
for the amount of fetal DNA present in maternal plasma
and serum across gestation will permit a determination
of the specific factors that affect these values. Will, for
example, the intrauterine growth–restricted fetus have
less DNA in the maternal plasma? Will the infected pla-
centa permit transfer of more fetal DNA into the
mother? Will measurement of fetal DNA in maternal
plasma ultimately be used as an indicator of fetal or
placental well-being? In a previous study, a variation in
the number of fetal cells detected among pregnant
women carrying karyotypically normal male fetuses was
noted (Bianchi et al. 1997). A statistically significant
increase in the number of fetal cells detectable in ma-
ternal blood when the fetus had Down syndrome was
also noted, leading to the hypothesis that there are pla-
cental abnormalities associated with aneuploidy. It
would be very interesting to know whether fetuses with
Down syndrome have increased amounts of fetal DNA
in their maternal plasma as well.
The authors envisage the primary clinical utility of
this assay to be determination of the presence of pater-
nally inherited polymorphisms associated with disease,
such as beta-globin mutations or rhesus D in a sensitized
mother (Camaschella et al. 1990; Lo et al. 1993; Cheung
et al. 1996). Although fetal aneuploidy might be sug-
gested by increased amounts of fetal DNA present in
maternal plasma, cytogenetic confirmation using intact
nuclei will ultimately be necessary. The major advance
of the Lo et al. (1998) study is that it demonstrates the
presence of relatively large amounts of fetal DNA in the
mother. This forces all of us to rethink the traditional
teaching that the fetal and maternal circulations are sep-
arated by a generally impermeable chorionic barrier. Fu-
ture experiments must be directed toward understanding
the maternal clinical implications of this extensive ex-
posure to “foreign” fetal DNA. The development of sen-
sitive methods that allow detection of previously unrec-
ognized amounts of fetal DNA in the maternal
circulation has, indeed, caused the plot to thicken.
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